Abstract
Abstract
The phosphatase calcineurin is a central component of many calcium signalling pathways, relaying calcium signals from the plasma membrane to the nucleus. It has critical functions in a multitude of systems, including immune, cardiac and neuronal. Given the widespread importance of calcineurin in both normal and pathological conditions, new tools that elucidate the spatiotemporal dynamics of calcineurin activity would be invaluable. Here we develop two separate genetically encoded fluorescence resonance energy transfer (FRET)-based sensors of calcineurin activation, DuoCaN and UniCaN. Both sensors showcase a large dynamic range and rapid response kinetics, differing primarily in the linker structure between the FRET pairs. Both sensors were calibrated in HEK293 cells and their responses correlated well with NFAT translocation to the nucleus, validating the biological relevance of the sensor readout. The sensors were subsequently expressed in neonatal rat ventricular myocytes and acutely isolated adult guinea pig ventricular myocytes. Both sensors demonstrated robust responses in myocytes and revealed kinetic differences in calcineurin activation during changes in pacing rate for neonatal versus adult myocytes. Finally, mathematical modelling combined with quantitative FRET measurements provided novel insights into the kinetics and integration of calcineurin activation in response to myocyte Ca transients. In all, DuoCaN and UniCaN stand as valuable new tools for understanding the role of calcineurin in normal and pathological signalling.
Key points
Novel fluorescence resonance energy transfer-based genetically encoded reporters of calcineurin are constructed by fusing the two subunits of calcineurin with P2A-based linkers retaining the expected native conformation of calcineurin.
Calcineurin reporters display robust responses to calcium transients in HEK293 cells. The sensor responses are correlated with NFATc1 translocation dynamics in HEK293 cells.
The sensors are uniformly distributed in neonatal myocytes and respond efficiently to single electrically evoked calcium transients and show cumulative activation at frequencies of 0.5 and 1 Hz.
In adult myocytes, the calcineurin sensors appear to be localized to the cardiac z-lines, and respond to cumulative calcium transients at frequencies of 0.5 and 1 Hz.
Introduction
The phosphatase calcineurin (PP2B) is a central component of many Ca2+signalling pathways relaying elevated Ca2+ signals from the plasma membrane to the nucleus. Structurally, calcineurin comprises two subunits, a catalytic subunit calcineurin-A (CaNA, ∼60 kDa) and a calcium binding subunit calcineurin-B (CaNB, ∼19 kDa) which is structurally similar to calmodulin (CaM). CaNA contains a catalytic phosphatase domain, a Ca2+/CaM binding domain, and an autoinhibitory domain that under basal calcium levels binds to and blocks the catalytic domain, preventing phosphatase activity (Li et al. 2011). The CaM-like CaNB subunit has four EF-hand domains capable of binding four calcium ions. The two calcium binding sites on the amino terminus bind calcium with high affinity and are occupied under basal calcium conditions (50–100 nm); by contrast, the two sites on the carboxy terminus bind calcium with lower affinity (Kd∼0.5 μm), and become occupied when intracellular calcium concentration ([Ca2+]i) rises, which together with Ca2+/CaM binding activates calcineurin (Klee et al. 1979,1998; Aramburu et al. 2000; Rusnak & Mertz, 2000; Yang & Klee, 2000). Once active, calcineurin initiates downstream signalling pathwaysrequired for cell adaptation, function and survival (Rusnak & Mertz, 2000). One of the most well-studied of these pathways is the activation of nuclear factor of activating T cells (NFAT), a critical component of T cell activation and proper immune function (Durand et al. 1988; Shaw et al. 1988).
Although the immune system has been the classic context for discoveries regarding the calcineurin–NFAT pathway, this pathway is also critical for diverse biological functions including axonal growth (Graef et al. 2003), learning and memory (Graef et al. 1999), and synaptic cycling and plasticity in the CNS(Sun et al. 2010; Sanderson et al. 2012). Moreover, proper calcineurin signalling is essential for the development of a wide range of cell types and tissues, including normal cardiac development (de la Pompa et al. 1998; Ranger et al. 1998), cardiac myocyte differentiation (Kasahara et al. 2013), pancreatic beta cell growth and function (Heit et al. 2006), and Schwann cell differentiation (Kao et al. 2009). It has also been discovered that disruption of the CaNB1subunit in the heart results in abnormal cardiac growth, impaired systolic and diastolic functions, and mortality (Schaeffer et al. 2009; Wolska, 2009). Moreover, calcineurin inhibition is suggested for potential therapeutic intervention in heart failure (Sussman et al. 1998). The broad importance of calcineurin signalling in normal and pathological conditions underlines the value of new tools capable of measuring calcineurin activation with spatiotemporal precision in live primary cells. Here, we deploy just such a tool in cardiac myocytes, providing new insights into calcineurin dynamics in these cells. Traditional biochemical methods have been instrumental in elucidating the basic biology and structure of calcineurin activation in different cell types (Klee & Krinks, 1978; Klee et al. 1979,1998; Crabtree, 1989; Liu et al. 1991; Jain et al. 1993; Stemmer & Klee, 1994). However, these assays are generally destructive and provide limited spatiotemporal resolution. Recent developments in fluorescent-based genetically encoded sensors have opened new vistas into studying the complex dynamics of signalling pathways in live cells (Takao et al. 2005; Newman & Zhang, 2008; Mehta et al. 2014). These sensors utilize fluorescence resonance energy transfer (FRET) to quantify conformational changes of proteins associated with activation (Jares-Erijman & Jovin, 2003). Following this idea, we developed two genetically encoded FRET-based calcineurin activity reporters, based on native calcineurin subunits, which feature rapid kinetic responses and suitable dynamic ranges in response to calcium signals in cardiomyocytes.
Methods
Molecular biology
To ensure a 1:1 stoichiometry of our calcineurin subunits we utilized a viral-based 2A sequence derived from porcine tescho virus (P2A) (Robertson et al. 1985; Ryan et al. 1991). This creates a P2A site for autonomous separation of the expressed fusion protein during translation, mimicking the normal expression of CaNA and CaNB as separate proteins. First, plasmids were created with several P2A sequence variations linking Cerulean and Venus. Cerulean was cloned into pCDNA3 (Clontech) using the KpnI and BamHI sites. Venus was then PCR amplified using a primer containing the P2A sequence and the product was cloned into the NotI and XbaI sites of the Cerulean pCDNA3 plasmid. This intermediate Cer-P2A-Ven plasmid was used to test cellular P2A hydrolysis, and the final sequence FQGPGATNFSLLKQAGDVEENPGPSLSK was chosen for creating the DuoCaN sensor. The underlined portion delineates P2A itself, with a flanking N-terminal sequence as indicated.
The Cer-P2A-Ven plasmid was then used to make the final DuoCaN plasmid using the plasmid pET15b CaNA-CaNB, a generous gift from Dr Anjana Rao (Addgene plasmid no. 11787). Calcineurin B was PCR amplified and cloned into the BamHI and NotI sites, and calcineurin A was PCR amplified and inserted into the XhoI and XbaI sites, replacing the existing Venus. Finally, Venus was cloned into the XbaI and ApaI sites, with a stop codon (TAA) preceding the ApaI site. This sensor should be cleaved between CaNA and CaNB after translation. The UniCaN sensor was constructed by the same method except that a modified mutated form of the P2A sequence was contained in the primer. The mutation consisted of a quadruple alanine substitution on the consensus P2A sequence (NPGP to AAAA). For adeno viral expression, sensors were sub-cloned into a pAdLox vector (Hardy et al. 1997) as follows: Venus was PCR amplified and ligated into the pAdLox via XbaI and EcoRI. PCR was then used to amplify the Cerulean-containing portion of DuoCaN or UniCaN (CER-CnB-P2Asequence-CnA) and the segment was ligated into the Venus-pAdLox plasmid using SalI and XbaI.
The mCherry-NFATc1 construct was made by inserting mCherry (Shaner et al. 2004) into human NFATc1 (Beals et al. 1997) which was a generous gift from Dr Gerald R. Crabtree (Addgene plasmid no. 24219) using HindIII and BamHI. The resulting mCherry-NFATc1 fusion construct was then subcloned into pcDNA3 via XhoI and XbaI.
Transfection into HEK293 cells
For calcium calibration of sensors and NFAT translocation experiments, HEK293 cells were cultured in glass-bottom dishes (In Vitro Scientific, Sunnyvale, CA, USA). The sensor constructs were transiently transfected using the Fugene transfection reagent (Promega, Madison, WI, USA) and the cells were imaged 24 h after transfection. For calcium calibration experiments, we applied 0.5–1 μg of the sensor construct. For translocation experiments, 1 μg of mCherry-NFAT and 1 μg of either UniCaN or DuoCaN were co-transfected ∼36 h before the experiment.
Virus production
Adenoviral vectors were generated using the Cre-Lox recombination system as previously described (Alseikhan et al. 2002; Colecraft et al. 2002; Limpitikul et al. 2014). Briefly, the DuoCaN and UniCaN pAdLox plasmids were co-transfected along with the ψ 5 vector into Cre8 cells allowing for expression and packaging of the viral particles. After three rounds of expansion in Cre8 cells, the viral particles were amplified in HEK293 cells and purified via a standard CsCl gradient protocol generating virus with a titre greater than 1010 particles/μl.
Myocyte culture
Neonatal rat ventricular myocytes (NRVMs) were isolated using standard protocols (Chlopcikova et al. 2001; Tung & Zhang, 2006) and plated on glass coverslips for 3–7 days prior to imaging. Adenoviruses containing either DuoCaN or UniCaN were added 24 h prior to imaging the myocytes. Adult guinea pig ventricular myocytes (aGPVMs) were isolated as described (Joshi-Mukherjee et al. 2013) and plated on laminin-coated glass coverslips in M199 media containing 20% fetal bovine serum (FBS). After 1 h, media were exchanged with 0% FBS M199 media and DuoCaN or UniCaN viruses were added. Eight to 12 h later, the myocytes were washed once with warmed PBS, and the media were replaced with fresh 0% FBS media. aGPVMs were imaged within 32 h of plating.
FRET/Ca co-imaging and Ca2+ calibration experiments
HEK293 cells expressing DuoCaN or UniCaN were loaded with 1 μm indo-1AM (Sigma-Aldrich, St Louis, MO, USA) as previously described (Tay et al. 2007). For Ca2+ calibration experiments, the cells were placed in Tyrode’s solution of varying external [Ca2+] (0, 100, 200 and 300 μM) to vary the amplitude of the [Ca2+]i rise induced by activating store-operated calcium entry portals. Calcium-free Tyrode buffered with 1 mm EGTA was used to elicit low-amplitude calcium transients. By plotting the cells with variable Ca2+ transient amplitudes we were able to populate the FRET/calcium calibration curves for UniCaN and DuoCaN. In HEK 293 cells, the transformation from indo-1 ratio to [Ca2+] (Grynkiewicz et al. 1985) is given by the following relation:
where .
For calcineurin activation–calcium calibrations, the FRET ratio (FR)was normalized as follows:
Recordings were done in a Tyrode’s solution consisting of 138 mm NaCl, 4 mm KCl, 1 mm MgCl2, 10 mm Hepes (pH 7.35 with NaOH) and 5 mm gluocose (all from Sigma-Aldrich). For direct [Ca2+]i measurements in NRVMs, the myocytes were incubated for 30 min with 1 μm indo-1AM along with 20% pluronic acid at 37°C. aGPVMs were loaded more readily and required only a 5 min incubation with 1 μm indo-1AM + 20% pluronic acid at room temperature. Electrical field stimulation was performed using a grass stimulator with platinum electrodes positioned ∼1 mm apart. The voltage amplitude for efficient field stimulation was in the range 10–20 V with a duration of 20–50 ms. Mechanical contraction of the cells under microscopic observation was used as an indicator for successful field stimulation. Calcium transients were recorded in response to electrical stimulation using 340 nm excitation and emission at both 405 and 485 nm. The UV excitation wavelength of indo-1 ensured no cross-talk with Cer fluorescence or FRET measurements. The normalized 405/485 nm fluorescence ratio () was used to infer [Ca2+]i. For DuoCaN and UniCaN recordings, cells were excited at 440 nm, and FRET emission was recorded at 530 nm, while CFP emission was recorded at 480 nm. The normalized FRET/CFP intensity ratio, was used as a measure of calcineurin activity, where and are the normalized intensities for FRET and CFP signals, respectively.
Indo-1 traces were low-pass filtered with a 20 kHz cutoff frequency, while the same filtering algorithm was performed on individual CFP and FRET traces with a 5 kHz cutoff. This filtering did not alter the FRET response of the sensors. The transient reduction in FRET and the corresponding rise in CFP signals in response to electrical stimulation were clearly identifiable from the raw traces. Bleaching in individual CFP and FRET channel signals (attributable to bleaching of CFP due to prolonged excitation) was corrected for by fitting an exponential function to the signal baseline. This bleaching effect, however, was mostly absent after taking the ratio of the signals to obtain and did not alter the final sensor response. The stimulation protocol included initial and final silent periods (no stimulation) which clearly indicated the baseline and bleaching effects, making fitting of the baselines straightforward. All analysis and data acquisition were performed with custom written software in MATLAB (Mathworks, Natick, MA, USA).
NFAT imaging
For NFAT translocation experiments, calcium-free Tyrode solution was used to achieve a low level of NFAT translocation and populate the lower part of the translocation-sensor response curve. Tyrode solution containing variable [Ca2+] (100, 200 or 300 μm) was used to achieve intermediate and complete NFAT translocation in order to populate the upper part of the correlation curve. Co-imaging of either DuoCaN or UniCaN with mCherry-NFATc1 was performed at 37°C with an LSM780 (Carl Zeiss, Oberkochen, Germany) confocal microscope with a mounted temperature-controlled chamber. All subsequent analysis and quantification of the sensor and NFATc1 translocation images were performed using ImageJ software (Schneider et al. 2012). NFAT translocation was quantified by the fraction of mCherry intensity in the nucleus versus the total whole-cell intensity using two-dimensional confocal images (mCherryNuclear/mCherryTotal). For time-lapse images, the imaging data were gathered every 30 s. Thapsigargin at 1 μm was added to the solution after 10–15 min of baseline imaging. This initial delay was included to obtain a sufficient fluorescence baseline.
Mathematical model of calcineurin activation
To capture the essential biology of calcineurin activation without increasing the number of parameters, we opted for a reduced version of a previously published model (Saucerman & Bers, 2008) that fitted our experimental data well. The following kinetic scheme describes the binding of four Ca2+ions to CaM and of two Ca2+ to CaNB, and the subsequent binding of Ca2+/CaM to the calcineurin complex:
The two conserved parameters are the free available CaM and free calcineurin:
Implying that C1 and C2 denote the available free CaM and calcineurin in the system.
The system of one-dimensional equations corresponding to the above reactions was solved in MATLAB (Mathworks). The following relation was used to fit the DuoCaN sensor data:
The values of the model parameters are tabulated in Table1.
Table 1.
Parameter | Description (value) | Reference |
---|---|---|
k20 | Off kinetics of 2 Ca2+ binding to apoCaM (10 s−1) | Saucerman & Bers (2008) |
k02 | On kinetics of 2 Ca2+ binding to apoCaM (10 μm−2 s−1) | |
Kd02 | 1 μm2 | Fit |
k42 | Off kinetics of 2 Ca2+ binding to Ca2CaM (1000 s−1) | Saucerman & Bers (2008) |
k24 | On kinetics of 2 Ca2+ binding to Ca2CaM (100 μm−2 s−1) | |
Kd42 | 10 μm2 | Fit |
KD,CnA | The dissociation constant for the binding of Ca2+/CaM to CN (100 pm) | Fit |
koff,CnA | Off kinetics of Ca2+/CaM binding to CN (1 s−1) | Fit |
kon,CnA | On kinetics of Ca2+/CaM binding to CN (104 μm−1 s−1) | |
Koff,CnB | The on kinetics of 2 Ca2+ binding to CaNB (1 s–1) | Fit |
KD,CnB | 0.5 μm2 | Saucerman & Bers (2008) |
kon,CnB | 2 μm−2 s−1 | |
C1 | Free available CaM | Fit |
C2 | Free available CN | Fit |
α | 0.1 | Fit |
β | 1 | Fit |
Quantification of the relative ratio of donor and acceptor molecules
FRET measurements for determining the stoichiometry of Cer to Ven-tagged molecules utilized the 33-FRET method (Erickson et al. 2001,2003), which we briefly describe here. The band-pass filters for the FRET cube were centred at 440nm (excitation) and 535 nm (emission). Signals measured with this cube have three components: donor fluorescence due to direct excitation, acceptor fluorescence due to direct excitation and acceptor fluorescence due to FRET. To determine the relative intensity of donor and acceptor fluorescence due to direct excitation, fluorescence signals due to indirect excitation need to be determined and removed. To accomplish this, constants RD1 (CFP crosstalk in the FRET cube), andRA1 (YFP crosstalk in the CFP signal) must be obtained. These are readily obtained as follows: for RD1, CFP is excited at 440 nm and emission at 535 nm is normalized by the emission at 480 nm. For RA1, the emission of YFP at 480 nm due to 440 nm excitation is normalized by the emission in response to a 515 nm excitation. This scheme allows the isolation of the pure FRET signals according the following:
To utilize these pure FRET signals to obtain the number of donor and acceptor molecules we utilize the following equations:
where GFRET is the average molar extinction coefficient of the acceptor (Venus) over the wavelength range 430–450nm for a given optical setup and FFRETis a parameter that incorporates the optical properties of the emission pathway. For more in-depths detail please see Erickson et al.(2001,2003).
Results
Design of FRET-based genetically encoded calcineurin reporters
To design robust calcineurin sensors, we exploited the conformational changes in calcineurin which occur following a rise in intracellular calcium. Full activation of calcineurin involves the displacement of the autoinhibitory domain by Ca2+-CaM binding and Ca2+-induced CaNB–CaNA changes, resulting in altered FRET (Fig.1A). We hypothesized that these conformational changes would be detectable by FRET and proceeded to fuse Cerulean (Cer) to the amino terminus of CaNB (CaNB1 isoform) and Venus (Ven) to the carboxy terminus of CaNA (CaNAα isoform) (Mondragon et al. 1997) (Fig.1A, B). To preserve the native 1:1 stoichiometry between CaNB1 and CaNAα, viral-based 2A sequences were employed as linker between the two calcineurin subunits (Robertson et al. 1985). These 2A sequences have been shown to undergo a self-hydrolysis reaction at the translational level, resulting in complete dissociation at the 2A site (Donnelly et al. 2001). The 2A sequence derived from porcine tescho virus (P2A) (Robertson et al. 1985; Ryan et al. 1991) was utilized as the linker for the calcineurin sensor. To optimize the effectiveness of P2A, several C–V dimer constructs with different P2A linkers between the two fluorophores were made. The self-processing efficacy of these P2A linkers was tested in live cells by utilizing a 33-FRET assay and by computing the number of expressed donor (Cer) and acceptor molecules (Ven) as previously described (Erickson et al. 2001,2003) and briefly described in the Methods section. Figure 1C shows the ratio of donor to acceptor molecules (ND and NA, respectively) for various forms of the P2A linker. Reassuringly, the ratio is nearly 1 for all the P2A constructs, indicating 1:1 stoichiometry.
To investigate whether the P2A linkers between Cer and Ven were fully hydrolyzed under basal conditions, the FRET ratio (FR) was plotted against the Cer fluorescence intensity (Fig.1D). All P2A linkers with a flanking amino terminal sequence had FR values close to 1 (as there is no inherent protein–protein interaction between Cer and Ven), indicating that the fluorescent proteins were completely separated. In contrast, the P2A sequence without the flanking amino terminal sequences (black) failed to cleave (high FR), consistent with previous observations (Szymczak et al. 2004; Kim et al. 2011). To confirm the efficiency of the P2A sequences, Fig.1E shows the result of a Western blot of the sensors expressed in HEK293 cells using an anti-GFP antibody. The complete processing of DuoCaN is demonstrated by the two bands corresponding to Cer-CnB (lower band, ∼46 kDa molecular weight) and CnA-Ven (upper band, ∼87 kDa molecular weight). Reassuringly, UniCaN does not cleave and yields a single band (molecular weight of 133 kDa). Given the successful cleavage of all the P2A variants, we opted to use the FQGPGP2A sequence to avoid the introduction of an inner methionine in the sensor. In addition, a quadruple alanine substitution within the consensus carboxy terminal NPGP consensus sequence (NPGP to AAAA) abolished the function of P2A and resulted in high FR values (Fig.1D cyan triangles).
Two sensors were constructed based on these findings. The first variant, called DuoCaN (dual calcineurin sensor, Fig.1A), was based on the FQGPGP2A sequence, which is fully severed inside cells. The second type of sensor, called UniCaN (unimolecular calcineurin sensor, Fig.1B), was constructed by using the quadruple alanine mutant form of the P2A sequence, which is non-functional (Fig.1D). DuoCaN is expected to be closer to the native conformation in cells, making it a valuable tool for assaying calcineurin dynamics under physiological conditions. However, targeting DuoCaN to different subcellular locations would be challenging. UniCaN circumvents this problem by fusing the two subunits together. Thus, the two sensors are complementary in their use.
Calibrating the calcium response of the sensors
Indo-1 was utilized to simultaneously measure [Ca2+]i and FRET responses of the sensors in HEK293 cells. Slow calcium transients were elicited by applying thapsigargin to activate store-operated Ca2+ influx. There was variability in calcium amplitudes elicited with thapsigargin even with the same extracellular Ca2+ (e.g. 200 μm). However, wider variations of calcium transient amplitudes were obtained by varying the external calcium concentration within the range 0–300 μm, thus fully populating the calibration curves. Figure 2A demonstrates the sensor response to thapsigargin-induced calcium transients for DuoCaN. The resultant calcium transient (Fig.2A1) activates calcineurin, which manifests as a decrease in the normalized FR of DuoCaN (Fig.2A2). The corresponding FRET signal (Fig.2A3) decreases while the CFP signal increases (Fig.2A4). The FR value then returns to basal level following the decay of the calcium transient. Figure 2B demonstrates a similar response for the UniCaN sensor, where the FR value, as well as FRET, and CFP signals follow the calcium transient. Both DuoCaN and UniCaN respond to the calcium transient with a ∼40% response. Remarkably, this response approaches 100%, when ionomycin is applied to HEK cells in which CaM is overexpressed (Fig.3), indicating a considerable dynamic range of the sensors. Because the thapsigargin-induced calcium transients develop and decay slowly, it is reasonable to assume that the calcium–calcineurin system stays near a quasi-equilibrium state. Assuming that HEK293 cells have enough free CaM to activate the sensor (a reasonable assumption based on a previous study utilizing a FRET-based CaM sensor in HEK293 cells; Liu et al. 2010), this feature of the system can be exploited to calibrate FR with [Ca2+]i. This is akin to phase-plane analysis of dynamical systems where the two time-varying states are plotted against each other (here FRNorm and calcium concentration, [Ca2+] as determined from indo-1 measurements). Accordingly, we plotted normalized FR () versus [Ca2+] at multiple time points for each cell (Fig.2C for DuoCaN and Fig.2D for UniCaN). The population data for both types of sensors were well fitted by a Hill equation with a Hill coefficient value of n = 3.8 and KD = 300 nm. The departure of the Hill coefficient from 6 (as would be predicted for the expected 6 calcium ions required for full activation) implies a high level of cooperativity between the 6 calcium binding sites. The Hill coefficient of 3.8 (implicating four Ca2+ ions required for activation) is quantitatively consistent with previous in vitro biochemical assays measuring the dependence of calcineurin phosphatase activity on calcium concentration (Stemmer & Klee, 1994), where strong cooperativity and a Hill coefficient of 3 were observed. Assuming that the Hill coefficients (n) are roughly the same for both activation (our assay) and activity (Stemmer and Klee) measurements, an algebraic manipulation implies that under the steady-state assumption, the activation assayed by our FRET sensors should be related to the in vitro calcineurin phosphatase activity by the following relation:
11 |
where KD,activity and KD,activation denote the calcium concentration required for half-maximal activity and conformational activation of calcineurin, respectively.
Coupling conformational FRET activation of the calcineurin sensors to NFAT nuclear translocation
DuoCaN and UniCaN are sensors of the conformational activation state of calcineurin, similar to the widely used CaMKII sensor Camuiα (Takao et al. 2005; Erickson et al., 2011). We showed that under steady-steady conditions the activation might be related to biochemically measured activity (eqn 11). However, this activation state may not be directly related to the dynamic phosphatase activity of calcineurin in live cells. We therefore employed NFAT translocation as a read-out of calcineurin activity to correlate calcineurin function with sensor activation. The specific fluorescent proteins employed within the sensors (Cer and Ven) allowed for measurement of mCherry-tagged NFAT in the presence of the sensor.
Adding thapsigargin to HEK cells again causes a rise in [Ca2+]i that activates calcineurin, resulting in NFAT translocation into the cell nucleus. Exemplar time-lapse images of mCherry-NFAT translocation into the nucleus are shown following the application of 1 μm thapsigargin at time 0 (Fig.4A DuoCaN, Fig.4F UniCaN). The fluorescent signals from the FRET (green) and CFP (blue) channels are shown in Fig.4B (DuoCaN) and Fig.4G (UniCaN), demonstrating the homogenous expression of the sensor within the cytosol. NFATc1 nuclear translocation was quantified by computing the ratio of nuclear red fluorescence to the whole-cell red fluorescence, (Fig.4C for DuoCaN and Fig.4H for UniCaN). The sensor response was simultaneously quantified by computing the normalized change in such that – 1). Figure4D illustrates the transient activation of DuoCaN, while Fig.4I shows the corresponding UniCaN response. The results indicate that a short transient (∼2.5 min) of calcineurin activation is sufficient for complete NFAT nuclear import (Fig.4C, D, H, I). While the sensor activation transient declines to near basal levels after ∼2.5 min, the fraction of nuclear NFAT continues to rise. This nuclear NFAT fraction reaches a steady-state level after 9 min. These observations are consistent with mathematical modelling of NFAT dynamics demonstrating that a high level of cooperativity between the 13 serine residues of NFAT can lead to a switch-like behaviour in NFAT activation dynamics (Salazar & Hofer, 2003, 2009).
The change in nuclear NFAT fraction at the plateau, , was correlated with the area under the curve of the sensor response () as shown in Fig.4E and J. Each point in Fig.4E and J corresponds to a single cell. Both DuoCaN and UniCaN population data were fitted with single exponential functions,
12 |
with c = 9, and A = 0.42 for DuoCaN and A = 0.45 for UniCaN. In fact, eqn12 is the solution of the following differential equation for Fn(t):
13 |
where kin(t) is the rate constant for fractional NFAT nuclear accumulation as shown in Fig.4A and F. Equation13 implies that . This relationship implies that the normalized sensor output is linearly related to the rate of NFAT nuclear import. In other words, this argues that the conformational activation observed by the sensors is linearly related to the activity assayed by the rate of NFAT nuclear import. Thus, the normalized sensor output (–ΔR/R0) is not only a measure of conformational activation, but also of calcineurin activity.
DuoCaN and UniCaN deployment in NRVMs
Given the remarkable response of DuoCaN and UniCaN in HEK293 cells, the sensors were deployed in primary cells equipped with native calcium cycling activity. NRVMs were chosen as a widely used model system featuring robust calcium transients in response to electric field stimulation in culture. Expression of either sensor demonstrated a nearly uniform cytoplasmic distribution (Fig.5E for DuoCaN and Fig.5E for UniCaN). No apparent toxicity was observed for the first 24 h of continuous expression.
Figure 5A illustrates the behaviour of DuoCaN in an exemplar NRVM. A single stimulation pulse elicited a strong calcium transient with a duration of ∼3 s as reported by the indo-1 calcium dye (Fig.5A1). Accordingly, the normalized FRET signal first decreased and then returned to the basal level (Fig.5A3) and the normalized CFP signal first increased and then returned to baseline (Fig.5A4). The ratio of these two signals was used as a read out of sensor activation (Fig.5A2). During 0.2 Hz stimulation (Fig.5B), DuoCaN responded with off kinetics of ∼5 s. However, faster pacing resulted in a cumulative effect on calcineurin activation (Fig.5C, D). To better quantify the on and off kinetics of the sensor, recordings included an unstimulated baseline prior to pacing, as well as a prolonged post-pacing interval, allowing return of the sensor signal to the baseline following the cessation of stimulation. This baseline signal also allowed for straightforward correction of the photobleaching effect shown in the raw traces (Fig.6). This accumulation of calcineurin activation is demonstrated by 0.5 Hz pacing of the cell in Fig.5C. The sensor response reached a steady-state value after about 13 s. Tetanus stimulation at 1 Hz (Fig.5D) resulted in similar accumulation of sensor activation, demonstrating a clear plateau in sensor response. The population data for versus frequency is shown in Fig.5F, demonstrating that the sensor activation reaches a maximum level of 0.06 with 1 Hz pacing. The population data for half-time to activation from a quiescent state (t1/2) are plotted against frequency in Fig.5G. This value reaches a maximum of 2 s by 0.5 Hz pacing frequency (Fig.5G).
UniCaN behaves similarly when deployed in NRVMs. It responds transiently to a single stimulus pulse with accumulated activation observed at pacing frequencies of 0.5 Hz or higher (Fig.7A–D). Interestingly, the maximum capacity of UniCaN activation (∼0.05, Fig.7F) is quite similar to that of DuoCaN (∼0.06, Fig.5F). On the other hand, the t1/2 as a function of frequency demonstrates a slower rise as compared to DuoCaN (Fig.7G versus Fig.5G). This could be due to the existence of a non-cleavable linker between the two subunits in UniCaN, which might slow down the response of the sensor due to steric hindrance.
Calcineurin activation dynamics in aGPVMs
We next deployed the sensors in acutely isolated aGPVMs,which are functionally more comparable to adult human ventricular myocytes than are NRVMs. aGPVMs possess all the major cellular structures and signalling pathways required for mature myocyte function. However, compared to NRVMs, aGPVMs have higher background fluorescence and are more resistant to DNA transfection, making them a challenging cell type for FRET-based sensor studies. Gratifyingly, adenoviral-mediated expression of DuoCaN and UniCaN in aGPVMs was efficient and caused no appreciable cell toxicity within 36 h. Strong z-line targeting of the sensors was observed as indicated by co-imaging with the membrane-localized dye di-4-ANNEPS (Fig.8E for DuoCaN and Fig.9E for UniCaN), consistent with the previously described localization pattern of calcineurin in cardiomyocytes (Santana et al. 2002).
Both DuoCaN and UniCaN displayed a functional response in aGPVMs that was distinctly different from their responses in NRVMs. In aGPVMs, the calcium transient elicited by a single electrical stimulus failed to activate the sensor (Fig.8A). A train of electrical stimuli at 0.2 Hz also induced only slight activation of either DuoCaN (Fig.8B2) or UniCaN (Fig.9B2) despite a large change in Ca2+ signal (Figs8B1 and 9B1). A significant sensor response was only seen upon increasing the pacing rate to 0.5 Hz (Figs8C and 9C). Under this condition, a cumulative sensor response was observed for both DuoCaN (Fig.8C) and UniCaN (Fig.9C). Notably, as in NRVMs, DuoCaN appeared to respond faster than UniCaN, reaching a clear plateau in activation. Stronger activation was observed with 1 Hz pacing, with DuoCaN again reaching a plateau (Fig.8D2) faster than the UniCaN sensor (Fig.9D2). Both the FRET (Fig.8D3) and the CFP (Fig.8D4) signals displayed strong amplitude fluctuations due to mechanical contractions of the myocyte. These large motion artifacts were compensated for in the signal (Fig.8D2). Thus, ratiometric sensors such as DuoCaN and UniCaN circumvent the need for the application of contraction blocking agents that could interfere with the normal calcium cycling processes of the cell. Altogether, DuoCaN and UniCaN have demonstrated robust signals in a useful and often challenging system.
The maximal amplitude of the sensor responses is similar in both NRVMs and in aGPVMs, as demonstrated by plotting the amplitude of the sensor response versus frequency. Both DuoCaN (Fig.8F) and UniCaN (Fig.9F) exhibit larger responses in amplitude as frequency increases, and their responses appear to plateau near the same values as in NRVMs (dashed line). The slope of the frequency-dependent rise in amplitude, however, is more steeply dependent on frequency in aGPVMs as compared to NRVMs, indicating a requirement for cumulative recruitment of calcineurin in adult myocytes. This is in contrast to responses in NRVMs where both sensors responded effectively to single pulses (Figs5A and 7A).
In addition to the difference in the frequency dependence of the sensor responses, there is also a major difference in the time course of sensor activation in aGPVMs as compared to NRVMs. Plotting t1/2 as a function of frequency for DuoCaN (Fig.8G) or UniCaN (Fig.9G) deployed in aGPVMs demonstrates a stark contrast with the same data from NRVMs (dashed line). The time constant for DuoCaN activation is 2.5-fold slower at 0.5 Hz pacing and 4-fold slower in response to 1 Hz pacing in aGPVMs than in NRVMs. A similar pattern is seen for UniCaN. As compared to NRVMs, a clear slowing of sensor activation can be seen. This difference in sensor activation kinetics in aGPVMs versus NRVMs hints at distinct mechanisms for calcineurin activation within the different milieu of the two cell types. Such dissimilarity within the two cell types is not unexpected given the localization pattern of calcineurin in aGPVMs, reinforcing this model system as a functional correlate to human ventricular myocytes.
Mathematical modelling of calcineurin sensor response in cardiomyocytes
The DuoCaN and UniCaN sensors provide a window into the dynamics of calcineurin activation in primary cardiomyocytes and offer the possibility of accurate estimation of important kinetic parameters for calcineurin activation in live cells. We thus utilized our myocyte data to constrain a kinetic model of calcineurin activation, allowing extrapolation of the binding rates for Ca2+ and Ca2+/CaM to the calcineurin complex. These parameters can be used to predict the activity of calcineurin in response to given calcium signals in diverse biological systems. The goal is thus to determine a single set of values for the dissociation constant of Ca2+/CaM from calcineurin, KD,CnA, and the dissociation rate of the same reaction, koff,CnA, capable of fitting both the NRVM and the aGPVM DuoCaN data. Note that DuoCaN is chosen for this model over the UniCaN sensor because it is expected to more closely approximate the native conformation of calcineurin. To begin, a simplified kinetic model was constructed based on a previous model of calcineurin dynamics in the heart (Saucerman & Bers, 2008) (see Methods for details). The DuoCaN sensor data were fitted with the assumption that the normalized fractional sensor response is proportional to the fraction of calcineurin in the full and partially active state (Ca4CaMCa4CN and Ca4N, respectively) such that:
14 |
where α and β are constants.Values for the binding of two Ca2+ ions to CaNB were set initially as KD,CnB = 0.5 μM and koff,CnB = 1 s−1 as reported based on steady-state biochemical assays (Saucerman & Bers, 2008). The parameters for Ca2+/CaM binding to CaNA were determined by fitting the model to the experimental data as follows.The calcium transients obtained with the indo-1 dye (Fig.10A black) were converted to true calcium concentrations and used as the system input allowing the model to be fit to the corresponding DuoCaN sensor data (Fig.10A red). Fitting this model to the DuoCaN data obtained in an NRVM paced at 0.1 Hz (Fig.10B black, note 1 – values are used for the fit) generates a predicted calcineurin response (red). The fit was obtained with the values KD,CnA = 100 pm, and koff,CnA = 1 s−1 for Ca2+/CaM binding to CaNA. Compared to the previously used value in a mathematical model (Saucerman & Bers, 2008), koff is 3 orders of magnitude faster, while the predicted KD for the same binding reaction is ∼3-fold larger. The same model could be fitted to sensor data from variable pacing frequencies in both NRVMs and aGPVMs (exemplars shown in Fig.10C, D), accurately predicting the sensor activation in the myocytes in response to multiple Ca2+ inputs. Remarkably, this model is capable of capturing both the activation and the inactivation trajectories of DuoCaN dynamics in NRVMs and aGPVMs. A single set of KD,CnA and koff,CnA values (Fig.10E) fitted the data in both NRVMs and aGPVMs, increasing our confidence in this result.
Careful inspection of the model inspired an interesting prediction for the parameter C1 (available free CaM in the system according to eqn 11). As demonstrated in Fig.10F, increasing C1 modulates the plateau amplitude of calcineurin activation for a given calcium train profile in aGPVMs. The steady-state activation value is almost doubled (to ∼0.1, blue trace) as C1 is increased from the fitted value of 30 nm (0.05, red trace) to 75 nm (blue trace). The steady-state value of activation is further increased as C1 is raised to 95 nm (∼0.2, green trace). In all, mathematical modelling combined with quantitative FRET measurements not only provided a method for determining the kinetic parameters of Ca2+ and Ca2+/CaM binding to calcineurin, but also generated an interesting hypothesis for how calcineurin could be modulated by other proteins (such as CaM) in various environments.
Discussion
The calcineurin reporters developed here showcase a 40% change in FR (Fig.2A2, B2) in response to thapsigargin-induced calcium release from the intracellular calcium stores, and a 100% change in response to an excess calcium load following ionomycin treatment in HEK293 cells overexpressing CaM (Fig.3). The suitable dynamic range and magnitude of response of these sensors were demonstrated by clear readouts of the time-dependent activation of calcineurin in neonatal and adult cardiomyocytes. These sensors substantially expand the repertoire of tools available to assay calcineurin–NFAT dynamics. In particular, they have a large dynamic range and more closely resemble endogenous calcineurin as compared to previously reported sensors (Newman & Zhang, 2008; Mehta et al. 2014). DuoCaN and UniCaN are the first to successfully capture dynamic calcineurin responses in primary cells. Deployment of the sensors in various cell types and tissues thus promises new insight into calcineurin signalling in numerous biological systems.
Differential calcineurin activation in neonatal and adult cardiomyocytes
Calcineurin readily activates in response to single calcium pulses in NRVMs, while in aGPVMs calcineurin seems to only activate at pacing frequencies that result in calcium accumulation from one pulse to the next. At higher frequencies, calcineurin activation is cumulative and follows the corresponding calcium train. Thus, the rapid heart rate of neonatal rats (∼320 b.p.m.) and human fetal myocytes (120–200 b.p.m.) may drive some level of continuous calcineurin activation leading to nuclear localization of NFAT (Fig.1A). This type of activity would be in agreement with the known role of the calcineurin/NFAT pathway in cardiac development (de la Pompa et al. 1998; Ranger et al. 1998; Schulz & Yutzey, 2004). Furthermore, this is also consistent with studies showing that NFAT is localized to the nucleus in 12% of NRVMs in quiescent culture conditions (MacDonnell et al. 2009). Adult myocytes appear to have a remarkably different pattern of calcineurin activity. In aGPVMs, calcineurin seems to respond only when there is a rise in basal calcium from one beat to the next. Thus, in human myocytes, where there is no beat-to-beat accumulation of calcium under normal conditions (Piacentino et al. 2003), calcineurin is likely to remain inactive under healthy conditions, consistent with the finding that calcineurin activation in adult myocytes would be pathologically hypertrophic (Sussman et al. 1998; Wilkins et al. 2004; van Berlo et al. 2013). The cumulative activation of calcineurin (Figs8 and 9) would predict nuclear localization of NFAT in adult myocytes. Such frequency-dependent localization of NFAT has indeed been shown in adult feline myocytes in culture, where increasing amounts of NFAT localization at faster pacing rates occurred (MacDonnell et al. 2009). It is reassuring that such a frequency-dependent increase in NFAT translocation agrees with the frequency dependence of calcineurin activation in aGPVMs observed with both DuoCaN and UniCaN sensors (Figs8F and 9F). In another study, the NFATc1 (but not NFATc3) isoform was shown to be localized to the nucleus under resting conditions in both atrial and ventricular myocytes and NFATc1 nuclear localization was reduced by inhibiting calcineurin (Rinne et al. 2010). This finding substantially adds to the complexity of the mechanisms involved in the transduction of the signals from calcineurin to different isoforms of NFAT, and necessitates the need for tools such as DuoCaN and UniCaN to help unravel the mechanisms underlying the precise control of Cn-NFAT signalling in cardiomyocytes.
It appears that there is a significant difference in neonatal versus adult myocyte calcineurin activation and NFAT localization. As we are able to describe both NRVM and aGPVM data with a single mechanistic kinetic model, we expect that this differential activation does not arise from fundamental differences in the pathways for calcineurin activation (Fig.1A). It is thus tempting to speculate that some of the differences in calcineurin activity between neonatal and adult myocytes may arise from the contrasting calcineurin localization pattern within these cells. In NRVMs both DuoCaN and UniCaN were homogeneous throughout the cytosol (Figs5E and7E), indicating a similar pattern for native calcineurin. In aGPVMs, on the other hand, a t-tubular localization pattern was seen (Figs8E and 9E). As dyadic calcium levels are expected to be greater than the cytoplasmic concentration (Despa et al. 2014), the reduced response of calcineurin in adult cells cannot result from a simple difference in calcium input. One possibility is that lower calcineurin activity in adult myocytes is partially due to co-localization of calcineurin near endogenous inhibitors such as AKAP79 (Li et al. 2012) and CaMKII (MacDonnell et al. 2009). In addition, differences in the amount of available local CaM may be involved, as follows. The maximum calcineurin activation in both NRVMs (Figs5F and 7F) and aGPVMs (Figs8F and 9F) was significantly lower than in HEK cells (Fig.2A2, B2), indicating that there may be a limiting reagent in the activation pathway. As both A and B subunits of calcineurin are overexpressed and a large Ca2+ transient was directly measured, CaM becomes the most likely candidate. Adjusting CaM concentrations in the kinetic model of calcineurin activation supports such a supposition. Increasing the amount of free CaM in the model enhanced the maximum level of calcineurin activation (Fig.10F). Applying this idea to NRVMs, CaM may be readily accessible to calcineurin in the cytosol, but at a lower free concentration as compared to HEK cells. In aGPVMs, dyadic localization may position calcineurin in an area with relatively lower levels of free CaM, an effect that may be amplified by decreased CaM expression due to culture conditions (Maier et al. 2006). While this is not known, recent observations show that CaM in adult myocytes is strongly buffered by ryanodine receptors that are in this dyadic region (Yang et al. 2014). The use of a FRET-based sensor of CaM was also shown to respond only in the presence of overexpressed CaM in cultured myocytes, further reinforcing the CaM availability hypothesis (Maier et al. 2006). Finally, this idea is also supported by a recent study that utilized a sensor of calcineurin to show that variations in subcellular CaM distribution can modulate the spatial and temporal dynamics of the calcineurin response (Mehta et al. 2014).
The differences in calcineurin activity between neonatal and adult myocytes may point to a common mechanism between developing and failing hearts. While calcineurin-driven NFAT translocation to the nucleus (Fig.1A) is known to promote pathological adult cardiac hypertrophy (Molkentin et al. 1998; Wilkins et al. 2004), constitutive activation of calcineurin might be necessary for the normal maturational hypertrophy of a developing myocyte (Fig.1B). Once the myocyte has matured, calcineurin activity would be reduced under normal physiological conditions. However, perturbations in calcium handling processes (Muth et al. 2001), altered levels of CaM (Gruver et al. 1993) and a myriad of other changes in the failing heart may lead to pathological activation of the calcineurin/NFAT pathway, resulting in hypertrophy of the adult heart (Fig.1B).
Future applications of the calcineurin sensors
Our results with DuoCaN and UniCaN provide support for the idea that FRET-based sensors can be exceptional tools for understanding normal and pathological signalling in biological systems. The two sensors could be used to test the aforementioned hypothesis that calcineurin may be highly active in failing hearts, providing new insight into cardiac pathophysiology. In addition, the sharp dependence of the model on levels of CaM makes the potential effect of recently discovered CaM mutations (Crotti et al. 2013; Limpitikul et al. 2014) on calcineurin dynamics an exciting new realm of inquiry. In addition, the sensors could be utilized to develop new targeted inhibitors of calcineurin that might exhibit lower liver and neurological toxicity (Palmer & Toto, 1991; Burdmann et al. 2003). Finally, given the robust response of the sensors in aGPVMs, a high probability of in vivo functionality is expected. Thus, the development of transgenic animals expressing DuoCaN or UniCaN looms as an exciting possibility. The unimolecular nature of UniCaN would allow subcellular targeting, adding a new dimension to the applicability of this sensor. In all, both DuoCaN and UniCaN stand as valuable new tools with which to probe calcineurin dynamics in a myriad of biological settings.
Acknowledgments
Over the years, we have been deeply inspired and touched by the kindness and generosity of our mentor Dr David Yue. We are grateful to have had the chance to work with him and learn from his profound and penetrating scientific vision. His death has left a deep scar in our hearts and in the field of calcium signalling. Dr Nancy Yue has been a strong advocate and supporter of the lab throughout the years and especially during this difficult time. We are inspired by her strength and are deeply grateful to her. We also thank Dr Don Bers and Dr Loren Looger for informative comments and discussions, Dr Manu Ben-Johny for optical imaging support and Dr Ting Liu and Dr Brian O’Rourke for providing resources, and assistance with aGPVM isolations. We thank all members of the Calcium Signals Lab (CSL) for their support throughout the years.
Glossary
- aGPVM
adult guinea pig ventricular myocyte
- CaM, calmodulin; CaNA
calcineurin-A
- CaNB
calcineurin-B
- DuoCaN
dual calcineurin sensor
- FRET, fluorescence resonance energy transfer; NFAT
nuclear factor of activating T cells
- NRVM
neonatal rate ventricular myocyte
- UniCaN
unimolecular calcineurin sensor
Additional information
Competing interests
No conflicts of interest.
Author contributions
D.T.Y. and H.B. designed the sensors and the linkers, and refined the experiments and hypothesis. H.B. performed the experiments, and carried out extensive analysis and mathematical modelling. L.J.S. contributed to the experiments and analysis in HEK cells. R.M. and I.E.D. isolated adult myocytes. I.E.D. and W.Y. contributed to adenoviral vector development. H.B., I.E.D. and L.J.S. wrote the paper utilizing D.T.Y.’s analysis and figures.
Funding
This study was supported by grants from NHLBI (D.T.Y), and the Kleberg Foundation (D.T.Y).
References
- Alseikhan BA, DeMaria CD, Colecraft HM. Yue DT. Engineered calmodulins reveal the unexpected eminence of Ca2+ channel inactivation in controlling heart excitation. Proc Natl Acad Sci U S A. 2002;99:17185–17190. doi: 10.1073/pnas.262372999. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Aramburu J, Rao A. Klee CB. Calcineurin: from structure to function. Curr Top Cell Regul. 2000;36:237–295. doi: 10.1016/s0070-2137(01)80011-x. [DOI] [PubMed] [Google Scholar]
- Beals CR, Clipstone NA, Ho SN. Crabtree GR. Nuclear localization of NF-ATc by a calcineurin-dependent, cyclosporin-sensitive intramolecular interaction. Genes Dev. 1997;11:824–834. doi: 10.1101/gad.11.7.824. [DOI] [PubMed] [Google Scholar]
- Burdmann EA, Andoh TF, Yu L. Bennett WM. Cyclosporine nephrotoxicity. Semin Nephrol. 2003;23:465–476. doi: 10.1016/s0270-9295(03)00090-1. [DOI] [PubMed] [Google Scholar]
- Chlopcikova S, Psotova J. Miketova P. Neonatal rat cardiomyocytes – a model for the study of morphological, biochemical and electrophysiological characteristics of the heart. Biomed PapMed FacUniv Palacky Olomouc Czech Repub. 2001;145:49–55. [PubMed] [Google Scholar]
- Colecraft HM, Alseikhan B, Takahashi SX, Chaudhuri D, Mittman S, Yegnasubramanian V, Alvania RS, Johns DC, Marban E. Yue DT. Novel functional properties of Ca2+ channel beta subunits revealed by their expression in adult rat heart cells. J Physiol. 2002;541:435–452. doi: 10.1113/jphysiol.2002.018515. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Crabtree GR. Contingent genetic regulatory events in T lymphocyte activation. Science. 1989;243:355–361. doi: 10.1126/science.2783497. [DOI] [PubMed] [Google Scholar]
- Crotti L, Johnson CN, Graf E, De Ferrari GM, Cuneo BF, Ovadia M, Papagiannis J, Feldkamp MD, Rathi SG, Kunic JD, Pedrazzini M, Wieland T, Lichtner P, Beckmann BM, Clark T, Shaffer C, Benson DW, Kaab S, Meitinger T, Strom TM, Chazin WJ, Schwartz PJ. George AL., Jr Calmodulin mutations associated with recurrent cardiac arrest in infants. Circulation. 2013;127:1009–1017. doi: 10.1161/CIRCULATIONAHA.112.001216. [DOI] [PMC free article] [PubMed] [Google Scholar]
- de la Pompa JL, Timmerman LA, Takimoto H, Yoshida H, Elia AJ, Samper E, Potter J, Wakeham A, Marengere L, Langille BL, Crabtree GR. Mak TW. Role of the NF-ATc transcription factor in morphogenesis of cardiac valves and septum. Nature. 1998;392:182–186. doi: 10.1038/32419. [DOI] [PubMed] [Google Scholar]
- Despa S, Shui B, Bossuyt J, Lang D, Kotlikoff MI. Bers DM. Junctional cleft [Ca2+]i measurements using novel cleft-targeted Ca2+ sensors. Circ Res. 2014;115:339–347. doi: 10.1161/CIRCRESAHA.115.303582. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, Gani D. Ryan MD. Analysis of the aphthovirus 2A/2B polyprotein ‘cleavage’ mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal ‘skip. J Gen Virol. 2001;82:1013–1025. doi: 10.1099/0022-1317-82-5-1013. & ’. [DOI] [PubMed] [Google Scholar]
- Durand DB, Shaw JP, Bush MR, Replogle RE, Belagaje R. Crabtree GR. Characterization of antigen receptor response elements within the interleukin-2 enhancer. Mol Cell Biol. 1988;8:1715–1724. doi: 10.1128/mcb.8.4.1715. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Erickson JR, Patel R, Ferguson A, Bossuyt J. Bers DM. Fluorescence resonance energy transfer-based sensor Camui provides new insight into mechanisms of calcium/calmodulin-dependent protein kinase II activation in intact cardiomyocytes. Circ Res. 2011;109:729–738. doi: 10.1161/CIRCRESAHA.111.247148. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Erickson MG, Alseikhan BA, Peterson BZ. Yue DT. Preassociation of calmodulin with voltage-gated Ca2+ channels revealed by FRET in single living cells. Neuron. 2001;31:973–985. doi: 10.1016/s0896-6273(01)00438-x. [DOI] [PubMed] [Google Scholar]
- Erickson MG, Liang H, Mori MX. Yue DT. FRET two-hybrid mapping reveals function and location of L-type Ca2+ channel CaM preassociation. Neuron. 2003;39:97–107. doi: 10.1016/s0896-6273(03)00395-7. [DOI] [PubMed] [Google Scholar]
- Graef IA, Mermelstein PG, Stankunas K, Neilson JR, Deisseroth K, Tsien RW. Crabtree GR. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature. 1999;401:703–708. doi: 10.1038/44378. [DOI] [PubMed] [Google Scholar]
- Graef IA, Wang F, Charron F, Chen L, Neilson J, Tessier-Lavigne M. Crabtree GR. Neurotrophins and netrins require calcineurin/NFAT signaling to stimulate outgrowth of embryonic axons. Cell. 2003;113:657–670. doi: 10.1016/s0092-8674(03)00390-8. [DOI] [PubMed] [Google Scholar]
- Gruver CL, DeMayo F, Goldstein MA. Means AR. Targeted developmental overexpression of calmodulin induces proliferative and hypertrophic growth of cardiomyocytes in transgenic mice. Endocrinology. 1993;133:376–388. doi: 10.1210/endo.133.1.8319584. [DOI] [PubMed] [Google Scholar]
- Grynkiewicz G, Poenie M. Tsien RY. A new generation of Ca2+ indicators with greatly improved fluorescence properties. J Biol Chem. 1985;260:3440–3450. [PubMed] [Google Scholar]
- Hardy S, Kitamura M, Harris-Stansil T, Dai Y. Phipps ML. Construction of adenovirus vectors through Cre-lox recombination. J Virol. 1997;71:1842–1849. doi: 10.1128/jvi.71.3.1842-1849.1997. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Heit JJ, Apelqvist AA, Gu X, Winslow MM, Neilson JR, Crabtree GR. Kim SK. Calcineurin/NFAT signalling regulates pancreatic beta-cell growth and function. Nature. 2006;443:345–349. doi: 10.1038/nature05097. [DOI] [PubMed] [Google Scholar]
- Jain J, McCaffrey PG, Miner Z, Kerppola TK, Lambert JN, Verdine GL, Curran T. Rao A. The T-cell transcription factor NFATp is a substrate for calcineurin and interacts with Fos and Jun. Nature. 1993;365:352–355. doi: 10.1038/365352a0. [DOI] [PubMed] [Google Scholar]
- Jares-Erijman EA. Jovin TM. FRET imaging. Nature Biotechnol. 2003;21:1387–1395. doi: 10.1038/nbt896. [DOI] [PubMed] [Google Scholar]
- Joshi-Mukherjee R, Dick IE, Liu T, O’Rourke B, Yue DT. Tung L. Structural and functional plasticity in long-term cultures of adult ventricular myocytes. J Mol Cell Cardiol. 2013;65:76–87. doi: 10.1016/j.yjmcc.2013.09.009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kao SC, Wu H, Xie J, Chang CP, Ranish JA, Graef IA. Crabtree GR. Calcineurin/NFAT signaling is required for neuregulin-regulated Schwann cell differentiation. Science. 2009;323:651–654. doi: 10.1126/science.1166562. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Kasahara A, Cipolat S, Chen Y, Dorn GW., 2nd Scorrano L. Mitochondrial fusion directs cardiomyocyte differentiation via calcineurin and Notch signaling. Science. 2013;342:734–737. doi: 10.1126/science.1241359. [DOI] [PubMed] [Google Scholar]
- Kim JH, Lee SR, Li LH, Park HJ, Park JH, Lee KY, Kim MK, Shin BA. Choi SY. High cleavage efficiency of a 2A peptide derived from porcine teschovirus-1 in human cell lines, zebrafish and mice. PLoS One. 2011;6:e18556. doi: 10.1371/journal.pone.0018556. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klee CB, Crouch TH. Krinks MH. Calcineurin: a calcium- and calmodulin-binding protein of the nervous system. Proc Natl Acad Sci USA. 1979;76:6270–6273. doi: 10.1073/pnas.76.12.6270. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Klee CB. Krinks MH. Purification of cyclic 3’,5’-nucleotide phosphodiesterase inhibitory protein by affinity chromatography on activator protein coupled to Sepharose. Biochemistry. 1978;17:120–126. doi: 10.1021/bi00594a017. [DOI] [PubMed] [Google Scholar]
- Klee CB, Ren H. Wang X. Regulation of the calmodulin-stimulated protein phosphatase, calcineurin. J Biol Chem. 1998;273:13367–13370. doi: 10.1074/jbc.273.22.13367. [DOI] [PubMed] [Google Scholar]
- Li H, Pink MD, Murphy JG, Stein A, Dell’Acqua ML. Hogan PG. Balanced interactions of calcineurin with AKAP79 regulate Ca2+-calcineurin–NFAT signaling. Nat Struct Mol Biol. 2012;19:337–345. doi: 10.1038/nsmb.2238. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Li H, Rao A. Hogan PG. Interaction of calcineurin with substrates and targeting proteins. Trends Cell Biol. 2011;21:91–103. doi: 10.1016/j.tcb.2010.09.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Limpitikul WB, Dick IE, Joshi-Mukherjee R, Overgaard MT, George AL., Jr Yue DT. Calmodulin mutations associated with long QT syndrome prevent inactivation of cardiac L-type Ca2+ currents and promote proarrhythmic behavior in ventricular myocytes. J Mol Cell Cardiol. 2014;74:115–124. doi: 10.1016/j.yjmcc.2014.04.022. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Liu J, Farmer JD, Jr, Lane WS, Friedman J, Weissman I. Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell. 1991;66:807–815. doi: 10.1016/0092-8674(91)90124-h. [DOI] [PubMed] [Google Scholar]
- Liu X, Yang PS, Yang W. Yue DT. Enzyme-inhibitor-like tuning of Ca2+ channel connectivity with calmodulin. Nature. 2010;463:968–972. doi: 10.1038/nature08766. [DOI] [PMC free article] [PubMed] [Google Scholar]
- MacDonnell SM, Weisser-Thomas J, Kubo H, Hanscome M, Liu Q, Jaleel N, Berretta R, Chen X, Brown JH, Sabri AK, Molkentin JD. Houser SR. CaMKII negatively regulates calcineurin–NFAT signaling in cardiac myocytes. Circ Res. 2009;105:316–325. doi: 10.1161/CIRCRESAHA.109.194035. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Maier LS, Ziolo MT, Bossuyt J, Persechini A, Mestril R. Bers DM. Dynamic changes in free Ca-calmodulin levels in adult cardiac myocytes. J Mol Cell Cardiol. 2006;41:451–458. doi: 10.1016/j.yjmcc.2006.04.020. [DOI] [PubMed] [Google Scholar]
- Mehta S, Aye-Han NN, Ganesan A, Oldach L, Gorshkov K. Zhang J. Calmodulin-controlled spatial decoding of oscillatory Ca2+ signals by calcineurin. Elife. 2014;3:e03765. doi: 10.7554/eLife.03765. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Molkentin JD, Lu JR, Antos CL, Markham B, Richardson J, Robbins J, Grant SR. Olson EN. A calcineurin-dependent transcriptional pathway for cardiac hypertrophy. Cell. 1998;93:215–228. doi: 10.1016/s0092-8674(00)81573-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mondragon A, Griffith EC, Sun L, Xiong F, Armstrong C. Liu JO. Overexpression and purification of human calcineurin alpha from Escherichia coli and assessment of catalytic functions of residues surrounding the binuclear metal center. Biochemistry. 1997;36:4934–4942. doi: 10.1021/bi9631935. [DOI] [PubMed] [Google Scholar]
- Muth JN, Bodi I, Lewis W, Varadi G. Schwartz A. A Ca2+-dependent transgenic model of cardiac hypertrophy: a role for protein kinase Cα. Circulation. 2001;103:140–147. doi: 10.1161/01.cir.103.1.140. [DOI] [PubMed] [Google Scholar]
- Newman RH. Zhang J. Visualization of phosphatase activity in living cells with a FRET-based calcineurin activity sensor. Mol Biosyst. 2008;4:496–501. doi: 10.1039/b720034j. [DOI] [PubMed] [Google Scholar]
- Palmer BF. Toto RD. Severe neurologic toxicity induced by cyclosporine A in three renal transplant patients. Am J Kidney Dis. 1991;18:116–121. doi: 10.1016/s0272-6386(12)80300-3. [DOI] [PubMed] [Google Scholar]
- Piacentino V, 3rd, Weber CR, Chen X, Weisser-Thomas J, Margulies KB, Bers DM. Houser SR. Cellular basis of abnormal calcium transients of failing human ventricular myocytes. Circ Res. 2003;92:651–658. doi: 10.1161/01.RES.0000062469.83985.9B. [DOI] [PubMed] [Google Scholar]
- Ranger AM, Grusby MJ, Hodge MR, Gravallese EM, de la Brousse FC, Hoey T, Mickanin C, Baldwin HS. Glimcher LH. The transcription factor NF-ATc is essential for cardiac valve formation. Nature. 1998;392:186–190. doi: 10.1038/32426. [DOI] [PubMed] [Google Scholar]
- Rinne A, Kapur N, Molkentin JD, Pogwizd SM, Bers DM, Banach K. Blatter LA. Isoform- and tissue-specific regulation of the Ca2+-sensitive transcription factor NFAT in cardiac myocytes and heart failure. Am J Physiol Heart Circ Physiol. 2010;298:H2001–H2009. doi: 10.1152/ajpheart.01072.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Robertson BH, Grubman MJ, Weddell GN, Moore DM, Welsh JD, Fischer T, Dowbenko DJ, Yansura DG, Small B. Kleid DG. Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J Virol. 1985;54:651–660. doi: 10.1128/jvi.54.3.651-660.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Rusnak F. Mertz P. Calcineurin: form and function. Physiol Rev. 2000;80:1483–1521. doi: 10.1152/physrev.2000.80.4.1483. [DOI] [PubMed] [Google Scholar]
- Ryan MD, King AM. Thomas GP. Cleavage of foot-and-mouth disease virus polyprotein is mediated by residues located within a 19 amino acid sequence. J Gen Virol. 1991;72:2727–2732. doi: 10.1099/0022-1317-72-11-2727. [DOI] [PubMed] [Google Scholar]
- Salazar C. Hofer T. Allosteric regulation of the transcription factor NFAT1 by multiple phosphorylation sites: a mathematical analysis. J Mol Biol. 2003;327:31–45. doi: 10.1016/s0022-2836(03)00085-8. [DOI] [PubMed] [Google Scholar]
- Salazar C. Hofer T. Multisite protein phosphorylation – from molecular mechanisms to kinetic models. FEBS J. 2009;276:3177–3198. doi: 10.1111/j.1742-4658.2009.07027.x. [DOI] [PubMed] [Google Scholar]
- Sanderson JL, Gorski JA, Gibson ES, Lam P, Freund RK, Chick WS. Dell’Acqua ML. AKAP150-anchored calcineurin regulates synaptic plasticity by limiting synaptic incorporation of Ca2+-permeable AMPA receptors. J Neurosci. 2012;32:15036–15052. doi: 10.1523/JNEUROSCI.3326-12.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Santana LF, Chase EG, Votaw VS, Nelson MT. Greven R. Functional coupling of calcineurin and protein kinase A in mouse ventricular myocytes. J Physiol. 2002;544:57–69. doi: 10.1113/jphysiol.2002.020552. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Saucerman JJ. Bers DM. Calmodulin mediates differential sensitivity of CaMKII and calcineurin to local Ca2+ in cardiac myocytes. Biophys J. 2008;95:4597–4612. doi: 10.1529/biophysj.108.128728. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schaeffer PJ, Desantiago J, Yang J, Flagg TP, Kovacs A, Weinheimer CJ, Courtois M, Leone TC, Nichols CG, Bers DM. Kelly DP. Impaired contractile function and calcium handling in hearts of cardiac-specific calcineurin b1-deficient mice. Am J Physiol Heart Circ Physiol. 2009;297:H1263–H1273. doi: 10.1152/ajpheart.00152.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schneider CA, Rasband WS. Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nat Methods. 2012;9:671–675. doi: 10.1038/nmeth.2089. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schulz RA. Yutzey KE. Calcineurin signaling and NFAT activation in cardiovascular and skeletal muscle development. Dev Biol. 2004;266:1–16. doi: 10.1016/j.ydbio.2003.10.008. [DOI] [PubMed] [Google Scholar]
- Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE. Tsien RY. Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol. 2004;22:1567–1572. doi: 10.1038/nbt1037. [DOI] [PubMed] [Google Scholar]
- Shaw JP, Utz PJ, Durand DB, Toole JJ, Emmel EA. Crabtree GR. Identification of a putative regulator of early T cell activation genes. Science. 1988;241:202–205. [PubMed] [Google Scholar]
- Stemmer PM. Klee CB. Dual calcium ion regulation of calcineurin by calmodulin and calcineurin B. Biochemistry. 1994;33:6859–6866. doi: 10.1021/bi00188a015. [DOI] [PubMed] [Google Scholar]
- Sun T, Wu XS, Xu J, McNeil BD, Pang ZP, Yang W, Bai L, Qadri S, Molkentin JD, Yue DT. Wu LG. The role of calcium/calmodulin-activated calcineurin in rapid and slow endocytosis at central synapses. J Neurosci. 2010;30:11838–11847. doi: 10.1523/JNEUROSCI.1481-10.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sussman MA, Lim HW, Gude N, Taigen T, Olson EN, Robbins J, Colbert MC, Gualberto A, Wieczorek DF. Molkentin JD. Prevention of cardiac hypertrophy in mice by calcineurin inhibition. Science. 1998;281:1690–1693. doi: 10.1126/science.281.5383.1690. [DOI] [PubMed] [Google Scholar]
- Szymczak AL, Workman CJ, Wang Y, Vignali KM, Dilioglou S, Vanin EF. Vignali DA. Correction of multi-gene deficiency in vivo using a single ‘self-cleaving’ 2A peptide-based retroviral vector. Nat Biotechnol. 2004;22:589–594. doi: 10.1038/nbt957. [DOI] [PubMed] [Google Scholar]
- Takao K, Okamoto K, Nakagawa T, Neve RL, Nagai T, Miyawaki A, Hashikawa T, Kobayashi S. Hayashi Y. Visualization of synaptic Ca2+/calmodulin-dependent protein kinase II activity in living neurons. J Neurosci. 2005;25:3107–3112. doi: 10.1523/JNEUROSCI.0085-05.2005. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tay LH, Griesbeck O. Yue DT. Live-cell transforms between Ca2+ transients and FRET responses for a troponin-C-based Ca2+ sensor. Biophys J. 2007;93:4031–4040. doi: 10.1529/biophysj.107.109629. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Tung L. Zhang Y. Optical imaging of arrhythmias in tissue culture. J Electrocardiol. 2006;39:S2–S6. doi: 10.1016/j.jelectrocard.2006.04.010. [DOI] [PubMed] [Google Scholar]
- van Berlo JH, Maillet M. Molkentin JD. Signaling effectors underlying pathologic growth and remodeling of the heart. J Clin Invest. 2013;123:37–45. doi: 10.1172/JCI62839. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Wilkins BJ, Dai YS, Bueno OF, Parsons SA, Xu J, Plank DM, Jones F, Kimball TR. Molkentin JD. Calcineurin/NFAT coupling participates in pathological, but not physiological, cardiac hypertrophy. Circ Res. 2004;94:110–118. doi: 10.1161/01.RES.0000109415.17511.18. [DOI] [PubMed] [Google Scholar]
- Wolska BM. Calcineurin and cardiac function: is more or less better for the heart? Am JPhysiol Heart Circ Physiol. 2009;297:H1576–H1577. doi: 10.1152/ajpheart.00833.2009. [DOI] [PubMed] [Google Scholar]
- Yang SA. Klee CB. Low affinity Ca2+-binding sites of calcineurin B mediate conformational changes in calcineurin A. Biochemistry. 2000;39:16147–16154. doi: 10.1021/bi001321q. [DOI] [PubMed] [Google Scholar]
- Yang Y, Guo T, Oda T, Chakraborty A, Chen L, Uchinoumi H, Knowlton AA, Fruen BR, Cornea RL, Meissner G. Bers DM. Cardiac myocyte Z-line calmodulin is mainly RyR2-bound, and reduction is arrhythmogenic and occurs in heart failure. Circ Res. 2014;114:295–306. doi: 10.1161/CIRCRESAHA.114.302857. [DOI] [PMC free article] [PubMed] [Google Scholar]